First COVID nasal vaccine by Bharat Biotech gets regulator's nod for holding phase 2, 3 clinical trials
Phase 1 clinical trial has been completed in age groups ranging from 18 to 60 years, the Department of Biotechnology said.
The national dashboard shows that 28.03 crore males and 24.91 crore women have received shots against so far and this marks a difference of nearly 12% between the two genders.
The team found that the antiviral response, driven by a family of proteins called interferons, was much more muted in patients who went on to develop severe COVID-19.
The study estimates that 1,134,000 children lost a parent or custodial grandparent due to COVID-19. Of these, 10,42,000 children lost their mother, father or both.
A total of five cases, that included a death after administration of Covishield in a 57-year-old male in February, however, were found to be “coincidental”, not directly linked with vaccination.
The total consumption, including wastages, is 26,04,19,412 doses, as per data available at 8 AM on Sunday.
UNEP country head Atul Bagai highlighted that climate change, pollution and loss of biodiversity are three crises facing the entire planet and India, and are interconnected.
Central ministries, including the Ministry of Civil Aviation and the Ministry of Health and Family Welfare, are currently discussing the matter with various other stakeholders, they added.
Twenty-five per cent vaccines will continue to be procured by private hospitals, but even here the maximum service charge has been capped at Rs 150 per jab.
These foreign nationals will not be required to submit any application to the FRRO or FRO concerned for extension of their visas.
India is also working with several other countries in the WTO on a targeted and temporary waiver under TRIPS to ensure timely and secure access to vaccines for all, the foreign secretary said.
These five senior pilots were Captain Harsh Tiwary, Captain G P S Gill, Captain Prasad Karmakar, Captain Sandeep Rana and Captain Amitesh Prasad, they said.
The states have also been asked to make suitable arrangements for isolation facilities within the CCIs to take care of the children suffering from Covid and prepare a roaster of child psychologists.
In order to boost production, the approval of 38 additional manufacturing sites were accelerated by the Government.
India has so far administered over 18 crore jabs to eligible beneficiaries.